CN110432483A - 一种类风湿关节炎专用型临床营养配方及其制备方法 - Google Patents
一种类风湿关节炎专用型临床营养配方及其制备方法 Download PDFInfo
- Publication number
- CN110432483A CN110432483A CN201910606493.6A CN201910606493A CN110432483A CN 110432483 A CN110432483 A CN 110432483A CN 201910606493 A CN201910606493 A CN 201910606493A CN 110432483 A CN110432483 A CN 110432483A
- Authority
- CN
- China
- Prior art keywords
- powder
- vitamin
- parts
- rheumatoid arthritis
- clinical nutrition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010039073 rheumatoid arthritis Diseases 0.000 title claims abstract description 55
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 37
- 230000035764 nutrition Effects 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 238000009472 formulation Methods 0.000 title description 15
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 31
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 26
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 26
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 20
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 18
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000011701 zinc Substances 0.000 claims abstract description 15
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 15
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 14
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940046009 vitamin E Drugs 0.000 claims abstract description 14
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 14
- 239000011709 vitamin E Substances 0.000 claims abstract description 14
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 13
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 13
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 13
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 13
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 13
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 13
- 239000010949 copper Substances 0.000 claims abstract description 13
- 229910052802 copper Inorganic materials 0.000 claims abstract description 13
- 230000035622 drinking Effects 0.000 claims abstract description 13
- 235000008216 herbs Nutrition 0.000 claims abstract description 13
- 230000010354 integration Effects 0.000 claims abstract description 13
- 229910052742 iron Inorganic materials 0.000 claims abstract description 13
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 13
- 239000011719 vitamin A Substances 0.000 claims abstract description 13
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 13
- 239000011718 vitamin C Substances 0.000 claims abstract description 13
- 229940045997 vitamin a Drugs 0.000 claims abstract description 13
- 235000019197 fats Nutrition 0.000 claims abstract description 11
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 11
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 11
- 239000011647 vitamin D3 Substances 0.000 claims abstract description 11
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims abstract description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229920001287 Chondroitin sulfate Polymers 0.000 claims abstract description 10
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 10
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 10
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000011575 calcium Substances 0.000 claims abstract description 10
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 10
- 235000001465 calcium Nutrition 0.000 claims abstract description 10
- 229940059329 chondroitin sulfate Drugs 0.000 claims abstract description 10
- 229960000304 folic acid Drugs 0.000 claims abstract description 10
- 235000019152 folic acid Nutrition 0.000 claims abstract description 10
- 239000011724 folic acid Substances 0.000 claims abstract description 10
- 239000011777 magnesium Substances 0.000 claims abstract description 10
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 10
- 235000001055 magnesium Nutrition 0.000 claims abstract description 10
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 10
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 10
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 10
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 10
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000005911 diet Nutrition 0.000 claims abstract description 9
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 9
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 9
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 9
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 9
- 235000018102 proteins Nutrition 0.000 claims abstract description 9
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 9
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 8
- 230000037213 diet Effects 0.000 claims abstract description 7
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 6
- 239000004615 ingredient Substances 0.000 claims abstract description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 5
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims abstract description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 4
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims description 115
- 239000003094 microcapsule Substances 0.000 claims description 24
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 13
- 239000011669 selenium Substances 0.000 claims description 12
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 11
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 11
- 102000007544 Whey Proteins Human genes 0.000 claims description 11
- 108010046377 Whey Proteins Proteins 0.000 claims description 11
- 229940091258 selenium supplement Drugs 0.000 claims description 11
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 10
- 235000010755 mineral Nutrition 0.000 claims description 10
- 239000011707 mineral Substances 0.000 claims description 10
- 229910052711 selenium Inorganic materials 0.000 claims description 10
- 235000003130 Arctium lappa Nutrition 0.000 claims description 9
- 235000008078 Arctium minus Nutrition 0.000 claims description 9
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 9
- 241000167854 Bourreria succulenta Species 0.000 claims description 9
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 9
- 244000008991 Curcuma longa Species 0.000 claims description 9
- 229920001353 Dextrin Polymers 0.000 claims description 9
- 239000004375 Dextrin Substances 0.000 claims description 9
- 244000246386 Mentha pulegium Species 0.000 claims description 9
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 9
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 9
- 239000001387 apium graveolens Substances 0.000 claims description 9
- 239000010495 camellia oil Substances 0.000 claims description 9
- 235000019693 cherries Nutrition 0.000 claims description 9
- 235000003373 curcuma longa Nutrition 0.000 claims description 9
- 235000019425 dextrin Nutrition 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- 229940029982 garlic powder Drugs 0.000 claims description 9
- 235000001050 hortel pimenta Nutrition 0.000 claims description 9
- 235000021388 linseed oil Nutrition 0.000 claims description 9
- 239000000944 linseed oil Substances 0.000 claims description 9
- -1 oligofructose Chemical compound 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 235000013976 turmeric Nutrition 0.000 claims description 9
- 229940088594 vitamin Drugs 0.000 claims description 9
- 229930003231 vitamin Natural products 0.000 claims description 9
- 235000013343 vitamin Nutrition 0.000 claims description 9
- 239000011782 vitamin Substances 0.000 claims description 9
- 240000005528 Arctium lappa Species 0.000 claims description 8
- 102000008186 Collagen Human genes 0.000 claims description 8
- 108010035532 Collagen Proteins 0.000 claims description 8
- 239000005862 Whey Substances 0.000 claims description 8
- 229920001436 collagen Polymers 0.000 claims description 8
- 235000013399 edible fruits Nutrition 0.000 claims description 8
- 235000010469 Glycine max Nutrition 0.000 claims description 7
- 244000068988 Glycine max Species 0.000 claims description 7
- 108010038807 Oligopeptides Proteins 0.000 claims description 7
- 102000015636 Oligopeptides Human genes 0.000 claims description 7
- 239000003292 glue Substances 0.000 claims description 7
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 7
- 239000005913 Maltodextrin Substances 0.000 claims description 6
- 229920002774 Maltodextrin Polymers 0.000 claims description 6
- 229940035034 maltodextrin Drugs 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 5
- 235000008390 olive oil Nutrition 0.000 claims description 5
- 239000004006 olive oil Substances 0.000 claims description 5
- 239000006041 probiotic Substances 0.000 claims description 5
- 235000018291 probiotics Nutrition 0.000 claims description 5
- URQMEZRQHLCJKR-UHFFFAOYSA-N 3-Methyl-5-propyl-2-cyclohexen-1-one Chemical compound CCCC1CC(C)=CC(=O)C1 URQMEZRQHLCJKR-UHFFFAOYSA-N 0.000 claims description 4
- 241000186000 Bifidobacterium Species 0.000 claims description 4
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 4
- 241000186012 Bifidobacterium breve Species 0.000 claims description 4
- 241000233866 Fungi Species 0.000 claims description 4
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 4
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 4
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 4
- 235000013312 flour Nutrition 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 239000011781 sodium selenite Substances 0.000 claims description 4
- 235000015921 sodium selenite Nutrition 0.000 claims description 4
- 229960001471 sodium selenite Drugs 0.000 claims description 4
- 241000251468 Actinopterygii Species 0.000 claims description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 3
- 229920001202 Inulin Polymers 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 244000098338 Triticum aestivum Species 0.000 claims description 3
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 3
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- 235000021323 fish oil Nutrition 0.000 claims description 3
- 239000004519 grease Substances 0.000 claims description 3
- 229940029339 inulin Drugs 0.000 claims description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 3
- 235000021119 whey protein Nutrition 0.000 claims description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims description 2
- 244000061520 Angelica archangelica Species 0.000 claims description 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 2
- 241000283690 Bos taurus Species 0.000 claims description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 2
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 2
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 2
- 108010000912 Egg Proteins Proteins 0.000 claims description 2
- 102000002322 Egg Proteins Human genes 0.000 claims description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 2
- 240000008669 Hedera helix Species 0.000 claims description 2
- 102000004407 Lactalbumin Human genes 0.000 claims description 2
- 108090000942 Lactalbumin Proteins 0.000 claims description 2
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 2
- 102000010445 Lactoferrin Human genes 0.000 claims description 2
- 108010063045 Lactoferrin Proteins 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- 235000009811 Momordica charantia Nutrition 0.000 claims description 2
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims description 2
- 240000001740 Momordica dioica Species 0.000 claims description 2
- 235000018365 Momordica dioica Nutrition 0.000 claims description 2
- 241000218231 Moraceae Species 0.000 claims description 2
- 235000008708 Morus alba Nutrition 0.000 claims description 2
- 229920001100 Polydextrose Polymers 0.000 claims description 2
- 244000234609 Portulaca oleracea Species 0.000 claims description 2
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 2
- 241000270273 Ptyas dhumnades Species 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 244000111146 Sonchus arvensis Species 0.000 claims description 2
- 235000008132 Sonchus arvensis ssp. uliginosus Nutrition 0.000 claims description 2
- 108010073771 Soybean Proteins Proteins 0.000 claims description 2
- 241000194017 Streptococcus Species 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 235000013339 cereals Nutrition 0.000 claims description 2
- 210000003022 colostrum Anatomy 0.000 claims description 2
- 235000021277 colostrum Nutrition 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 2
- 235000005489 dwarf bean Nutrition 0.000 claims description 2
- 244000013123 dwarf bean Species 0.000 claims description 2
- 235000014103 egg white Nutrition 0.000 claims description 2
- 210000000969 egg white Anatomy 0.000 claims description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 2
- 235000008397 ginger Nutrition 0.000 claims description 2
- 230000003301 hydrolyzing effect Effects 0.000 claims description 2
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 2
- 235000021242 lactoferrin Nutrition 0.000 claims description 2
- 229940078795 lactoferrin Drugs 0.000 claims description 2
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 claims description 2
- 239000001259 polydextrose Substances 0.000 claims description 2
- 235000013856 polydextrose Nutrition 0.000 claims description 2
- 229940035035 polydextrose Drugs 0.000 claims description 2
- 235000019710 soybean protein Nutrition 0.000 claims description 2
- 235000008939 whole milk Nutrition 0.000 claims description 2
- 235000021241 α-lactalbumin Nutrition 0.000 claims description 2
- 241000186660 Lactobacillus Species 0.000 claims 2
- 229940039696 lactobacillus Drugs 0.000 claims 2
- 235000012054 meals Nutrition 0.000 claims 2
- 244000294263 Arctium minus Species 0.000 claims 1
- 244000302544 Luffa aegyptiaca Species 0.000 claims 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- 244000046052 Phaseolus vulgaris Species 0.000 claims 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 150000005672 tetraenes Chemical class 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 abstract description 23
- 229940108928 copper Drugs 0.000 abstract description 11
- 229960003284 iron Drugs 0.000 abstract description 11
- 230000001228 trophic effect Effects 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 3
- 230000000968 intestinal effect Effects 0.000 abstract description 3
- 229960005069 calcium Drugs 0.000 abstract 1
- 229940091250 magnesium supplement Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 238000011443 conventional therapy Methods 0.000 description 8
- 238000005303 weighing Methods 0.000 description 8
- 206010003246 arthritis Diseases 0.000 description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 7
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 6
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 5
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 5
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 5
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 235000010930 zeaxanthin Nutrition 0.000 description 5
- 239000001775 zeaxanthin Substances 0.000 description 5
- 229940043269 zeaxanthin Drugs 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 240000005809 Prunus persica Species 0.000 description 4
- 235000006040 Prunus persica var persica Nutrition 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 230000002596 correlated effect Effects 0.000 description 4
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 4
- 238000007599 discharging Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 229960000984 tocofersolan Drugs 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 244000116699 Lactobacillus acidophilus NCFM Species 0.000 description 3
- 235000009195 Lactobacillus acidophilus NCFM Nutrition 0.000 description 3
- 241000254697 Lactobacillus rhamnosus HN001 Species 0.000 description 3
- 235000003956 Luffa Nutrition 0.000 description 3
- 244000050983 Luffa operculata Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 235000013734 beta-carotene Nutrition 0.000 description 3
- 239000011648 beta-carotene Substances 0.000 description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 3
- 229960002747 betacarotene Drugs 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 229960000485 methotrexate Drugs 0.000 description 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000002076 α-tocopherol Substances 0.000 description 3
- 235000004835 α-tocopherol Nutrition 0.000 description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 108010063738 Interleukins Proteins 0.000 description 2
- 102000015696 Interleukins Human genes 0.000 description 2
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- 229940087168 alpha tocopherol Drugs 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000005482 chemotactic factor Substances 0.000 description 2
- 239000011666 cyanocobalamin Substances 0.000 description 2
- 229960002104 cyanocobalamin Drugs 0.000 description 2
- 235000000639 cyanocobalamin Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229940047122 interleukins Drugs 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 208000018937 joint inflammation Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000001258 synovial membrane Anatomy 0.000 description 2
- 102000003390 tumor necrosis factor Human genes 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-IKTKBOKFSA-N 4-oxo-4-[[(2S)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid Chemical compound CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(CC1)Oc(c(C)c2C)c1c(C)c2OC(CCC(O)=O)=O IELOKBJPULMYRW-IKTKBOKFSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 108010092277 Leptin Proteins 0.000 description 1
- 102000016267 Leptin Human genes 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000947 anti-immunosuppressive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 230000006472 autoimmune response Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229940108924 conjugated linoleic acid Drugs 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229940116318 copper carbonate Drugs 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- GEZOTWYUIKXWOA-UHFFFAOYSA-L copper;carbonate Chemical compound [Cu+2].[O-]C([O-])=O GEZOTWYUIKXWOA-UHFFFAOYSA-L 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- FWBOFUGDKHMVPI-UHFFFAOYSA-K dicopper;2-oxidopropane-1,2,3-tricarboxylate Chemical compound [Cu+2].[Cu+2].[O-]C(=O)CC([O-])(C([O-])=O)CC([O-])=O FWBOFUGDKHMVPI-UHFFFAOYSA-K 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 239000011640 ferrous citrate Substances 0.000 description 1
- 235000019850 ferrous citrate Nutrition 0.000 description 1
- 239000011773 ferrous fumarate Substances 0.000 description 1
- 235000002332 ferrous fumarate Nutrition 0.000 description 1
- 229960000225 ferrous fumarate Drugs 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 230000027950 fever generation Effects 0.000 description 1
- 239000004833 fish glue Substances 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- APVZWAOKZPNDNR-UHFFFAOYSA-L iron(ii) citrate Chemical compound [Fe+2].OC(=O)CC(O)(C([O-])=O)CC([O-])=O APVZWAOKZPNDNR-UHFFFAOYSA-L 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
- 229940039781 leptin Drugs 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000010731 swelling symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明涉及一种类风湿关节炎专用型临床营养配方,其包括:蛋白质、脂肪、膳食纤维、膳食精华、药食同源成分、维生素A、维生素D3、维生素E、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、烟酸、叶酸、泛酸、镁、钙、铁、锌、铜、硫酸软骨素;本发明还涉及上述临床营养配方的制备方法。本发明通过选用合理的基础营养素,基于类风湿关节炎患者的营养摄入,对各组分的配比进行适应性调整,同时添加具有保护肠道功能和营养辅助支持的特殊营养素,以实现营养均衡,改善类风湿关节炎患者营养结构,辅助改善类风湿关节炎患者的机体健康状况。
Description
技术领域
本发明涉及特殊医学用途配方食品领域,具体涉及一种类风湿关节炎专用型临床营养配方及其制备方法。
背景技术
类风湿关节炎是一种关节发炎的症状,当免疫系统过渡的活化,导致对身体的伤害,与其它自身免疫的疾病相同,类风湿关节炎也是一种自我侵袭的疾病,在这种状况之下,身体的免疫系统不适当的作用而将本身的滑液膜当成外来物质,而产生发炎反应,伤害关节附近的软骨和组织,通常,骨头的表面也会受到破坏,因此关节发炎产生的一些细胞因子、趋化因子和金属蛋白酶会慢慢消化附近的组织。身体又以结疤组织来取代这些受伤的组织,使得关节附近的正常空间变狭窄,而骨头则接连在一起。对称性、进展性的外周关节炎是类风湿关节炎的主要特征,受累关节结构进行性破坏,并常伴有全身症状。会有僵硬、肿胀、疲倦、贫血、体重减轻、发烧,以及经常会有麻痛发生。
骨关节炎只影响个别的关节,而类风湿关节炎则会影响到身体的所有滑液性关节。类风湿关节炎在人群中的患病率大约是1%。类风湿关节炎多见于35-50岁人群,其中女性患病率比男性多2-3倍。根据统计现今美国约有210万人患有此疾病,而其中的75%是女性。幼年型的关节炎则是一种侵袭16岁以下小孩的风湿性关节炎,大约有71000位美国青少年受到此疾病的影响,而且几乎全部都是女性。
尽管有自身免疫反应参与其中,类风湿关节炎确切病因仍不明,可由许多因素所致。类风湿关节炎的形成原因可能是由于生理或情绪的压力、营养不良及细菌感染等。临床上类风湿关节炎常见的治疗药物分为三大类:非甾体类抗炎药、糖皮质激素及改善病情的抗风湿药。甲氨蝶呤为抗风湿药的首选药物,但是会带来乏力、发热等全身症状,上腹部不适,食欲不振,口腔破溃,消化道出血等消化道症状,血细胞三系减少等不良反应。上述药物往往因疗效不如意或毒副作用较大而难以推广或长期使用。目前市场上没有关于类风湿关节炎的肠内营养制剂产品。
因此,开发一种适用于类风湿关节炎患者以改善其营养结构从而维持营养均衡的营养配方是十分必要的。
发明内容
本发明的目的在于克服现有技术中的缺陷,针对类风湿关节炎患者饮食结构不合理、营养不均匀等不良现状,提供一种类风湿关节炎专用型临床营养配方,该营养配方作为类风湿关节炎的肠内营养制剂,通过膳食调控,合理搭配碳水化合物、蛋白质、脂肪的供给能量比值,选择多种维生素、矿物质、药食同源成分,来改善类风湿关节炎患者营养结构,辅助改善类风湿关节炎患者的机体健康状况。
为实现上述目的,本发明采用如下技术方案:
本发明的第一个目的是提供一种类风湿关节炎专用型临床营养配方,其包括如下组分及其重量份数:蛋白质20-25份、脂肪2-6份、膳食纤维35-50份、膳食精华0.4-8份、药食同源成分0.5~5份、维生素A 0.0005-0.0015份、维生素D3 0.0003-0.0009份、维生素E0.015-0.035份、维生素B1 0.001-0.003份、维生素B2 0.001-0.003份、维生素B6 0.001-0.003份、维生素B12 0.000002-0.000006份、维生素C 0.15-0.25份、烟酸0.01-0.02份、叶酸0.01-0.05份、泛酸0.003-0.008份、镁0.10-0.3份、钙0.3-0.8份、铁0.01-0.02份、锌0.005-0.015份、铜0.0002~0.0004份、硫酸软骨素0.002~0.004份。
为了进一步优化上述临床营养配方,本发明所采取的技术措施还包括:
进一步地,所述蛋白质选自水解乳清蛋白粉、浓缩乳清蛋白粉、大豆分离蛋白、全蛋粉、牛初乳粉、全脂奶粉、白蛋白肽、大豆肽、海洋鱼低聚肽、小麦低聚肽、玉米低聚肽粉、α-乳清蛋白粉、乳铁蛋白、鱼胶原蛋白肽中的至少一种。更优选为乳清蛋白粉(水解乳清蛋白粉和浓缩乳清蛋白粉)和鱼胶原蛋白肽。
进一步地,所述脂肪选自橄榄油微囊粉、茶油微囊粉、鱼油微囊粉、亚麻籽油微囊粉、二十二碳六烯酸油脂、花生四烯酸油脂中的至少一种。更优选为亚麻籽油微囊粉、橄榄油微囊粉、茶油微囊粉中的至少一种;其中,饱和脂肪酸:单不饱和脂肪酸:多不饱和脂肪酸约为1:1:1,橄榄油和茶油中油酸(C18:1)含量达79%-83%。
进一步地,所述膳食纤维选自菊粉、聚葡萄糖、低聚半乳糖、低聚果糖、低聚木糖、低聚异麦芽糖、抗性糊精、大豆纤维等谷物膳食纤维中的至少一种。更优选为抗性糊精。
进一步地,所述膳食精华包括樱桃粉、海带粉、牛蒡根粉、大蒜粉、芹菜籽粉、苦瓜粉、苦菜粉、马齿苋粉、丝瓜粉、薏仁粉、豆腐粉、芹菜粉、扁豆粉、香菇粉、黑木耳粉中的至少一种。更优选为:樱桃粉、海带粉、牛蒡根粉、大蒜粉、芹菜籽粉。
进一步地,所述药食同源成分包括山药、乌梢蛇、甘草、白芷、白扁豆、沙棘、生姜、桑葚、鲜芦根、薏苡仁、姜黄、薄荷、沙棘、黄精中的至少一种。更优选为:姜黄、薄荷、沙棘、黄精。其中,药食同源的中药材经过炮制、粉碎成100-200目的细粉。
进一步地,维生素A来源于醋酸视黄酯、棕榈酸视黄酯、β-胡萝卜素中的至少一种。
进一步地,维生素C来源于L-抗坏血酸、L-抗坏血酸钠中的至少一种。
进一步地,维生素E来源于d-α-生育酚、dl-α-生育酚、d-α-醋酸生育酚、dl-α-醋酸生育酚、d-α-琥珀酸生育酚、dl-α-琥珀酸生育酚中的至少一种。维生素E可促进n-3脂肪酸的作用,有研究表明调节白细胞介素(IL)-6,IL-10,IL-12和肿瘤坏死因子(TNF)-α水平,延缓大鼠模型自身免疫性疾病的发生
进一步地,维生素D来源于胆钙化醇、麦角钙化醇中的至少一种。
进一步地,维生素B1来源于盐酸硫胺素、硝酸硫胺素中的至少一种。
进一步地,维生素B2来源于核黄素中的至少一种。
进一步地,维生素B6来源于盐酸吡哆醇、5’-磷酸吡哆醛中的至少一种。
进一步地,维生素B12来源于氰钴胺、盐酸氰钴胺中的至少一种。
进一步地,锌来源于硫酸锌、葡萄糖酸锌、氧化锌、乳酸锌、柠檬酸锌中的至少一种。
进一步地,铜来源于葡萄糖酸铜、硫酸铜、柠檬酸铜、碳酸铜中的至少一种。
进一步地,铁来源于葡萄糖酸亚铁、柠檬酸亚铁、柠檬酸铁、富马酸亚铁、乳酸亚铁、焦磷酸铁中的至少一种。
有研究表明:抗氧化维生素和矿物质能抑制促炎性细胞因子leptin、TNF-α、IL-6的水平,同时提高抑炎性细胞因子IL-10的水平。降低CIA大鼠的关节炎指数。Bae等将97例类风湿关节炎患者,按年龄性别配对,对照组97例进行病例对照研究,以食物半定量调查表评价营养摄人。每组提供20例血标本,并化验血浆α-生育酚、丙二醛、超氧化物歧化酶和谷胱甘肽过氧化物酶活性,发现类风湿关节炎患者比对照组热量摄入低,脂肪、维生素A和β-胡萝卜素显著低于对照组。类风湿关节炎患者血浆。α-生育酚均降低,血浆超氧化物歧化酶和谷胱甘肽过氧化物酶活性显著低于对照组。Cerhan等对29368例55-69岁妇女进行了为期10年观察,其中有152例被确诊为类风湿关节炎。在控制其他危险因素下,给予维生素C(最高和最低量)支持和维生素E支持与类风湿关节炎呈负相关。与总类胡萝卜素、α-胡萝卜素、β-胡萝卜素、茄红素、叶黄素、玉米黄质无相关性。但与玉米黄质呈负相关。锌支持与类风湿关节炎呈负相关。铜支持、锰支持与类风湿关节炎也呈负相关。水果和十字花科蔬菜也呈负相关,只有玉米黄质和锌支持在统计学上有意义。表明玉米黄质和锌支持,高水果和十字花科蔬菜摄人能缓解类风湿关节炎的症状。大样本含量的队列研究显示血清中硒水平较高可防止进展,并且有假设认为血清中硒含量增加可暂时性降低发病率,且研究表明,患者血清硒的水平明显低于正常人。
进一步地,所述营养配方还包括益生菌0.5~3份,所述益生菌选自双歧杆菌属、乳杆菌属、链球菌属、嗜酸乳杆菌NCFM、动物双歧杆菌Bb-12、乳双歧杆菌HN019、乳双歧杆菌Bi-07、鼠李糖乳杆菌LGG、鼠李糖乳杆菌HN001、发酵乳杆菌CECT5716、短双歧杆菌M-16V中的至少一种。
进一步地,所述营养配方还包括硒0.005~0.08份,所述硒来源亚硒酸钠、富硒食用菌粉、富硒酵母中的至少一种。
进一步地,所述营养配方还包括新资源食品1~4份,所述新资源食品包括DHA藻油、鱼油及提取物、花生四烯酸油脂、γ-亚麻酸油脂、牡丹籽油、茶叶籽油、翅果油、御米油、共轭亚油酸、杜仲籽油、菊粉、低聚果糖、低聚木糖、低聚甘露糖、小麦低聚肽、壳聚糖、人参(人工种植)、玉米黄质、水解蛋黄粉、植物乳杆菌中的至少一种;其中,油脂以微囊粉的形式添加。
进一步地,所述营养配方包括抗性糊精、乳清蛋白粉、亚麻籽油微囊粉、姜黄、鱼胶原蛋白肽、樱桃粉、海带粉、牛蒡根粉、大蒜粉、芹菜籽粉、薄荷、沙棘粉、黄精粉、镁、钙、铁、锌、铜、维生素A、维生素D3、维生素E、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、泛酸、烟酸、叶酸、硫酸软骨素;更进一步地,该营养配方还包括:亚硒酸钠、嗜酸乳杆菌NCFM、鼠李糖乳杆菌HN001、短双歧杆菌M-16V、丝瓜粉、豆腐粉、芹菜粉、黑木耳粉、茶叶籽油微囊粉、橄榄油微囊粉、茶油微囊粉。
本发明的第二个目的是提供一种上述类风湿关节炎专用型临床营养配方的制备方法方法,其包括如下步骤:称取预定量的各原料,其中维生素、复合矿物质、药食同源成分、脂肪预先制备成预混料;将预混料和2%麦芽糊精先混合5~15分钟;将其它原料按照逐级递增的原则加入进行混合,混合10~30分钟,出料,分装。
进一步地,上述各原料均为粒径为50~200μm的粉末形式的原料,配置前及配置完成后均经过杀菌处理。
进一步地,所述营养配方的剂型包括营养粉、营养乳剂、胶囊剂、片剂、丸剂、口服液等。
与现有技术相比,本发明具有以下有益效果:
本发明通过饮食治疗作为缓解患者关节疼痛症状的一种辅助措施。根据我国传统中医药的理论,通过证论治的食疗基本原则,结合患者体质特征,使用一种或多种药食同源的中药材、新资源食品、可用于食品的益生菌、短肽类、不饱和脂肪酸、水溶性膳食纤维、具有抗氧化功能的多种维生素和多种矿物质制成的具有预防和缓解类风湿关节炎症状的全营养或非全营养配方食品。
本发明营养配方补充丰富的高生物价优质蛋白质,优质蛋白质有益于人体消化吸收系统的吸收利用,全面均衡地补充人体所需的8种必须氨基酸,防止出现负氮平衡,提高免疫力;且添加适量的膳食纤维,以调节胃肠道功能并间接缓解类风湿关节炎的症状。本发明选用的脂肪富含n-3脂肪酸,同时添加维生素E,其可促进n-3脂肪酸的作用,对类风湿关节炎有抗炎和免疫抑制作用。
本发明添加适量的抗氧化维生素和矿物质,包括维生素A、β-胡萝卜素、维生素C、维生素E、B族维生素、铜、硒、锌、铁。适量的抗氧化营养素可以减少自由基产生并清除滑膜细胞中的氧自由基,防止氧化损伤,并改善类风湿关节炎患者抗氧化能力。同时补充硒,其能降低关节肿胀,改善晨僵症状,降低血清水平。
本发明营养配方还可包含肠道益生菌,其对于维持免疫稳态、调节内皮生长分化、保护细胞等方面均具有重要作用,肠道菌群的失调通过促进炎症反应等多种机制促进类风湿关节炎的发生;因此,适量添加肠道益生菌可辅助治疗类风湿关节炎。
本发明营养配方还可添加具有清热解毒的功效,可以缓解局部发热、发痛等;具有健脾利湿的功效,可用于缓解肿胀症状;具有提高人体免疫力的作用,可以缓解局部的红肿热痛等症状的膳食精华,以辅助治疗类风湿关节炎。
本发明通过选用合理的基础营养素,基于类风湿关节炎患者的营养摄入,对各组分的配比进行适应性调整,同时添加具有保护肠道功能和营养辅助支持的特殊营养素,以实现营养均衡,改善类风湿关节炎患者营养结构,辅助改善类风湿关节炎患者的机体健康状况。
具体实施方式
本发明提供一种类风湿关节炎专用型临床营养配方,其包括如下组分及其重量份数:蛋白质20-25份、脂肪2-6份、膳食纤维35-50份、膳食精华0.4-8份、药食同源成分0.5~5份、维生素A 0.0005-0.0015份、维生素D3 0.0003-0.0009份、维生素E 0.015-0.035份、维生素B1 0.001-0.003份、维生素B2 0.001-0.003份、维生素B6 0.001-0.003份、维生素B120.000002-0.000006份、维生素C 0.15-0.25份、烟酸0.01-0.02份、叶酸0.01-0.05份、泛酸0.003-0.008份、镁0.10-0.3份、钙0.3-0.8份、铁0.01-0.02份、锌0.005-0.015份、铜0.0002~0.0004份、硫酸软骨素0.002~0.004份。
下面结合实施例,对本发明的具体实施方式作进一步描述。以下实施例仅用于更加清楚地说明本发明的技术方案,而不能以此来限制本发明的保护范围。
实施例1
本发明所述的类风湿关节炎专用型临床营养配方包括以下组分:
抗性糊精40g、乳清蛋白粉22g、亚麻籽油微囊粉4.5g、姜黄4g、鱼胶原蛋白肽2g、樱桃粉2g、海带粉1g、牛蒡根粉1g、大蒜粉1g、芹菜籽粉1g、薄荷1g、沙棘粉1g、黄精粉1g、镁0.16g、钙0.5g、铁0.017g、锌0.013g、铜0.0003g、维生素A 0.0012g、维生素D3 0.0006g、维生素E 0.02g、维生素B1 0.002g、维生素B2 0.002g、维生素B6 0.002g、维生素B120.000004g、维生素C 0.2g、泛酸0.005g、烟酸0.015g、叶酸0.03g、硫酸软骨素0.004g
制备方法:按照组分表称量各组分,其中维生素、矿物质、药食同源和脂肪原料按照表格先制备成制备预混料;将预混料和2%麦芽糊精先混合10分钟;然后将其它物料按照逐级递增的原则投入混合机,混合20分钟,出料,称重记录,分装。
实施例2
本发明所述的类风湿关节炎专用型临床营养配方包括以下组分:
抗性糊精40g、乳清蛋白粉22g、亚麻籽油微囊粉2g、姜黄0.4g、鱼胶原蛋白肽2g、樱桃粉0.2g、海带粉0.1g、牛蒡根粉0.1g、大蒜粉0.1g、芹菜籽粉0.1g、薄荷0.1g、沙棘粉0.1g、黄精粉0.1g、镁0.16g、钙0.5g、铁0.017g、锌0.013g、铜0.0003g、维生素A 0.0012g、维生素D3 0.0006g、维生素E 0.02g、维生素B1 0.002g、维生素B2 0.002g、维生素B6 0.002g、维生素B12 0.000004g、维生素C 0.2g、泛酸0.005g、烟酸0.015g、叶酸0.03g、硫酸软骨素0.004g
制备方法:按照组分表称量各组分,其中维生素、矿物质、药食同源和脂肪原料按照表格先制备成制备预混料;将预混料和2%麦芽糊精先混合10分钟;然后将其它物料按照逐级递增的原则投入混合机,混合20分钟,出料,称重记录,分装。
实施例3
本发明所述的类风湿关节炎专用型临床营养配方包括以下组分:
抗性糊精40g、乳清蛋白粉22g、亚麻籽油微囊粉2g、姜黄0.4g、鱼胶原蛋白肽2g、樱桃粉0.2g、海带粉0.1g、牛蒡根粉0.1g、大蒜粉0.1g、芹菜籽粉0.1g、薄荷0.1g、沙棘粉0.1g、黄精粉0.1g、镁0.16g、钙0.5g、铁0.017g、锌0.013g、铜0.0003g、维生素A 0.0012g、维生素D3 0.0006g、维生素E 0.02g、维生素B1 0.002g、维生素B2 0.002g、维生素B6 0.002g、维生素B12 0.000004g、维生素C 0.2g、泛酸0.005g、烟酸0.015g、叶酸0.03g、硫酸软骨素0.0001g
制备方法:按照组分表称量各组分,其中维生素、矿物质、药食同源和脂肪原料按照表格先制备成制备预混料;将预混料和2%麦芽糊精先混合10分钟;然后将其它物料按照逐级递增的原则投入混合机,混合20分钟,出料,称重记录,分装。
实施例4
本发明所述的类风湿关节炎专用型临床营养配方包括以下组分:
抗性糊精42g、乳清蛋白粉19g、亚麻籽油微囊粉2g、姜黄0.3g、鱼胶原蛋白肽4g、樱桃粉0.5g、海带粉0.2g、牛蒡根粉0.2g、大蒜粉0.2g、芹菜籽粉0.2g、薄荷0.2g、沙棘粉0.2g、黄精粉0.2g、镁0.16g、钙0.5g、铁0.017g、锌0.013g、铜0.0003g、维生素A 0.0012g、维生素D3 0.0006g、维生素E 0.02g、维生素B1 0.002g、维生素B2 0.002g、维生素B6 0.002g、维生素B12 0.000004g、维生素C 0.2g、泛酸0.005g、烟酸0.015g、叶酸0.03g、硫酸软骨素0.0003g、亚硒酸钠0.1g、嗜酸乳杆菌NCFM 0.5g、鼠李糖乳杆菌HN001 0.5g、短双歧杆菌M-16V 0.5g、丝瓜粉0.15g、豆腐粉0.15g、芹菜粉0.15g、黑木耳粉0.15g、茶叶籽油微囊粉1g、橄榄油微囊粉1g、茶油微囊粉1g。
制备方法:按照组分表称量各组分,其中维生素、矿物质、药食同源、脂肪和新资源食品原料按照表格先制备成制备预混料;将预混料和2%麦芽糊精先混合10分钟;然后将其它物料按照逐级递增的原则投入混合机,混合20分钟,出料,称重记录,分装。
应用实施例
本实施例采用实施例1制备的营养粉对60名类风湿关节炎患者进行试验,随机分为2组,第1组患者进行常规治疗(甲氨蝶呤),第2组患者进行常规治疗(甲氨蝶呤)的同时服用实施例1制备的营养粉,每次15mg,以90ml温水冲泡,每日3次,治疗周期均为3个月。
观测指标:治疗3个月期间的晨僵时间、关节肿胀指数、关节压痛指数、双手平均握力。
消化道症状:治疗3个月期间的上腹疼痛、烧灼感、反酸、恶心、呕吐、嗳气、腹胀等消化系统症状。
治疗3个月后,其疗效结果如下:
组别 | 有效 | 无效 |
常规治疗组 | 19 | 11 |
常规治疗+营养粉组 | 26 | 4 |
治疗3个月,其消化道不良反应统计如下:
组别 | 有不良反应 | 无不良反应 |
常规治疗组 | 9 | 21 |
常规治疗+营养粉组 | 2 | 28 |
由上可知,常规治疗+营养粉组比单独常规治疗相比,其治疗有效率较高,且其不良反应较低,这说明本发明制备的营养配方,可作为类风湿关节炎的日常营养均衡制剂,且其能有效缓解药物治疗引起的消化道的不良反应,辅助治疗类风湿关节炎。
以上对本发明的具体实施例进行了详细描述,但其只作为范例,本发明并不限制于以上描述的具体实施例。对于本领域技术人员而言,任何对本发明进行的等同修改和替代也都在本发明的范畴之中。因此,在不脱离本发明的精神和范围下所作的均等变换和修改,都应涵盖在本发明的范围内。
Claims (10)
1.一种类风湿关节炎专用型临床营养配方,其特征在于,包括如下组分及其重量份数:蛋白质20-25份、脂肪2-6份、膳食纤维35-50份、膳食精华0.4-8份、药食同源成分0.5~5份、维生素A 0.0005-0.0015份、维生素D3 0.0003-0.0009份、维生素E 0.015-0.035份、维生素B1 0.001-0.003份、维生素B2 0.001-0.003份、维生素B6 0.001-0.003份、维生素B120.000002-0.000006份、维生素C 0.15-0.25份、烟酸0.01-0.02份、叶酸0.01-0.05份、泛酸0.003-0.008份、镁0.10-0.3份、钙0.3-0.8份、铁0.01-0.02份、锌0.005-0.015份、铜0.0002~0.0004份、硫酸软骨素0.002~0.004份。
2.根据权利要求1所述的一种类风湿关节炎专用型临床营养配方,其特征在于,所述蛋白质选自水解乳清蛋白粉、浓缩乳清蛋白粉、大豆分离蛋白、全蛋粉、牛初乳粉、全脂奶粉、白蛋白肽、大豆肽、海洋鱼低聚肽、小麦低聚肽、玉米低聚肽粉、α-乳清蛋白粉、乳铁蛋白、鱼胶原蛋白肽中的至少一种。
3.根据权利要求1所述的一种类风湿关节炎专用型临床营养配方,其特征在于,所述脂肪选自橄榄油微囊粉、茶油微囊粉、鱼油微囊粉、亚麻籽油微囊粉、二十二碳六烯酸油脂、花生四烯酸油脂中的至少一种。
4.根据权利要求1所述的一种类风湿关节炎专用型临床营养配方,其特征在于,所述膳食纤维选自菊粉、聚葡萄糖、低聚半乳糖、低聚果糖、低聚木糖、低聚异麦芽糖、抗性糊精、大豆纤维等谷物膳食纤维中的至少一种。
5.根据权利要求1所述的一种类风湿关节炎专用型临床营养配方,其特征在于,所述膳食精华包括樱桃粉、海带粉、牛蒡根粉、大蒜粉、芹菜籽粉、苦瓜粉、苦菜粉、马齿苋粉、丝瓜粉、薏仁粉、豆腐粉、芹菜粉、扁豆粉、香菇粉、黑木耳粉中的至少一种。
6.根据权利要求1所述的一种类风湿关节炎专用型临床营养配方,其特征在于,所述药食同源成分包括山药、乌梢蛇、甘草、白芷、白扁豆、沙棘、生姜、桑葚、鲜芦根、薏苡仁、姜黄、薄荷、沙棘、黄精中的至少一种。
7.根据权利要求1所述的一种类风湿关节炎专用型临床营养配方,其特征在于,所述营养配方还包括益生菌0.5~3份,所述益生菌选自双歧杆菌属、乳杆菌属、链球菌属、嗜酸乳杆菌NCFM、动物双歧杆菌Bb-12、乳双歧杆菌HN019、乳双歧杆菌Bi-07、鼠李糖乳杆菌LGG、鼠李糖乳杆菌HN001、发酵乳杆菌CECT5716、短双歧杆菌M-16V中的至少一种。
8.根据权利要求1所述的一种类风湿关节炎专用型临床营养配方,其特征在于,所述营养配方还包括硒0.005~0.08份,所述硒来源于亚硒酸钠、富硒食用菌粉、富硒酵母中的至少一种。
9.根据权利要求1所述的一种类风湿关节炎专用型临床营养配方,其特征在于,所述营养配方包括抗性糊精、乳清蛋白粉、亚麻籽油微囊粉、姜黄、鱼胶原蛋白肽、樱桃粉、海带粉、牛蒡根粉、大蒜粉、芹菜籽粉、薄荷、沙棘粉、黄精粉、镁、钙、铁、锌、铜、维生素A、维生素D3、维生素E、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、泛酸、烟酸、叶酸、硫酸软骨素。
10.一种如权利要求1~9中任一项所述的类风湿关节炎专用型临床营养配方的制备方法,其特征在于,包括如下步骤:称取预定量的各原料,其中维生素、复合矿物质、药食同源成分和脂肪预先制备成预混料;将预混料和2%麦芽糊精先混合5~15分钟;将其它原料按照逐级递增的原则加入进行混合,混合10~30分钟,出料,分装。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910606493.6A CN110432483A (zh) | 2019-07-05 | 2019-07-05 | 一种类风湿关节炎专用型临床营养配方及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910606493.6A CN110432483A (zh) | 2019-07-05 | 2019-07-05 | 一种类风湿关节炎专用型临床营养配方及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110432483A true CN110432483A (zh) | 2019-11-12 |
Family
ID=68429542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910606493.6A Pending CN110432483A (zh) | 2019-07-05 | 2019-07-05 | 一种类风湿关节炎专用型临床营养配方及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110432483A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116195741A (zh) * | 2021-11-30 | 2023-06-02 | 内蒙古伊利实业集团股份有限公司 | 乳双歧杆菌bb-12在保护软骨中的应用 |
RU2813891C1 (ru) * | 2023-09-28 | 2024-02-19 | Общество с ограниченной ответственностью "ДИАМЕД-фарма" | Фармацевтическое средство для лечения артрологических заболеваний |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104146201A (zh) * | 2014-08-18 | 2014-11-19 | 胡安然 | 类风湿关节炎全营养配方食品 |
CN104872644A (zh) * | 2015-04-24 | 2015-09-02 | 劲膳美生物科技股份有限公司 | 类风湿关节炎非全营养配方食品 |
CN105029400A (zh) * | 2015-04-10 | 2015-11-11 | 劲膳美生物科技股份有限公司 | 类风湿关节炎医学配方食品 |
CN106579393A (zh) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | 一种糖尿病专用型临床营养配方及其制备方法 |
CN106983151A (zh) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | 一种炎性肠病专用型临床营养配方及其制备方法 |
CN108013454A (zh) * | 2017-12-13 | 2018-05-11 | 上海奥医生物医药科技有限公司 | 妇科炎症专用型临床营养配方及其制备方法 |
-
2019
- 2019-07-05 CN CN201910606493.6A patent/CN110432483A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104146201A (zh) * | 2014-08-18 | 2014-11-19 | 胡安然 | 类风湿关节炎全营养配方食品 |
CN105029400A (zh) * | 2015-04-10 | 2015-11-11 | 劲膳美生物科技股份有限公司 | 类风湿关节炎医学配方食品 |
CN104872644A (zh) * | 2015-04-24 | 2015-09-02 | 劲膳美生物科技股份有限公司 | 类风湿关节炎非全营养配方食品 |
CN106579393A (zh) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | 一种糖尿病专用型临床营养配方及其制备方法 |
CN106983151A (zh) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | 一种炎性肠病专用型临床营养配方及其制备方法 |
CN108013454A (zh) * | 2017-12-13 | 2018-05-11 | 上海奥医生物医药科技有限公司 | 妇科炎症专用型临床营养配方及其制备方法 |
Non-Patent Citations (1)
Title |
---|
张天民等: "硫酸软骨素的过去、现在和将来", 《食品与药品》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116195741A (zh) * | 2021-11-30 | 2023-06-02 | 内蒙古伊利实业集团股份有限公司 | 乳双歧杆菌bb-12在保护软骨中的应用 |
RU2813891C1 (ru) * | 2023-09-28 | 2024-02-19 | Общество с ограниченной ответственностью "ДИАМЕД-фарма" | Фармацевтическое средство для лечения артрологических заболеваний |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1992351B1 (en) | Lactobacillus johnsonii for prevention of postsurgical infection | |
KR101911205B1 (ko) | 배변유도 및 다이어트용 조성물과 이의 제조방법 | |
CN106174585A (zh) | 降血糖的组合物及降血糖的复合益生菌特膳食品 | |
US6900173B2 (en) | Perioperative multivitamin protein bar for use in preparing an individual for fast surgical recovery | |
WO2015058563A1 (zh) | 提高免疫力的天然复合粉及其制备方法和应用 | |
JP7296454B2 (ja) | 炎症関連胃腸障害の処置のためのプロバイオティクスの組み合わせ | |
JP7407195B2 (ja) | アレルギー性疾患の治療のためのプロバイオティクスの組み合わせ | |
CN109846035A (zh) | 一种具有体重控制功效的复合益生菌组合物 | |
CN110226744A (zh) | 一种前列腺炎专用型临床营养配方及其制备方法 | |
CN104855985A (zh) | 尿酸高非全营养配方食品 | |
CN110432482A (zh) | 一种小儿过敏性皮炎专用型临床营养配方及其制备方法 | |
CN111955720A (zh) | 一种产妇产后催乳特殊膳食及其制备方法 | |
CN102283342B (zh) | 航天用功能性全营养流食及其制备方法 | |
CN107334156A (zh) | 催乳全营养配方食品 | |
CN104187643A (zh) | 阳虚体质全营养配方食品 | |
CN109156530A (zh) | 一种辅食营养包及其生产工艺 | |
CN104839685A (zh) | 创伤感染手术及其它应急状态医学配方食品 | |
CN110432483A (zh) | 一种类风湿关节炎专用型临床营养配方及其制备方法 | |
CN109380734A (zh) | 一种克罗恩氏病患者专用特膳食品 | |
CN105995981A (zh) | 一种含有益生菌微囊的全营养特殊医学用途配方食品及其制备方法 | |
CN117958446B (zh) | 一种减重降体脂的组合物、制备方法及其应用 | |
Sunil | Exploratory Evaluation of a Customized Feed Supplement for Early Weaning in Piglets | |
CN104839677A (zh) | 阳虚体质医学配方食品 | |
CN108936606A (zh) | 骨关节退行性病变全营养配方食品 | |
CN109043520A (zh) | 心肌梗塞患者食用的特定全营养配方食品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191112 |
|
RJ01 | Rejection of invention patent application after publication |